Investing.com - Santhera Pharmas Holding reported on Thursday second quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
Santhera Pharmas Holding announced earnings per share of CHF-0.20 on revenue of CHF1.7M. Analysts polled by Investing.com EPS of CHF-0.20 on revenue of CHF1.7M.
Santhera Pharmas Holding 's are down 41.35% and is trading at CHF1.31 , still down 20.61% from its 52 week high of CHF1.65 set on Monday, January 17, 2022.
Santhera Pharmas Holding follows other major Healthcare sector earnings this month
Santhera Pharmas Holding's report follows an earnings matched by Abcam on Monday, September 12, 2022, who reported EPS of CHF0.14 on revenue of CHF185.2M, EPS of CHF0.14 on revenue of CHF194.64M.
Oxford Nanopore Tech had beat expectations on Tuesday, September 13, 2022 with second quarter EPS of CHF-0.04 on revenue of CHF122.3M, for EPS of CHF-0.08 on revenue of CHF72.50M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar